A Boston-based pharma consulting firm, Bioviser is looking to expand into the Oceanic region and it’s starting Down Under.
Client Partner, Simon Davis, who is based in Australia and has extensive development experience, is currently exploring business needs and identifying the scope for customized consultancy solutions that aim to influence positive patient outcomes.
“The Oceanic territory is vast but full of potential,” Davis said. “I am excited to scope this opportunity to work with pharmaceutical and healthcare companies here and complement Bioviser’s dynamic expansion plans.
“We are here to provide time-tested and bespoke medical and regulatory services with our personable, highly qualified, and skilled team to ensure client and patient success.”
Founded three years ago, Bioviser has quickly expanded its global reach with clients in medium- to-large pharmaceutical and biotech companies across North America, Europe, India, Singapore, and Japan.
Bioviser’s President for Japan and Oceania, Haruyoshi Ogata, said: “We believe in extending our decisive and dedicated efforts to all in need.”
The firm creates medical content and documentation, to support market access, reimbursement, and evidence creation among many other bespoke scientific and regulatory activities.
“Where there is a need, Bioviser is determined to make its effective business solutions easily accessible,” Bioviser’s CEO, Ivan Dsouza, said.
“We are passionate about creating meaningful impact every day in the healthcare and pharmaceutical industries.”